Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Yu Liu

Showing results (251-260 of 296) with videos related to

Pageof 30
Sort By:
Thoracic Cancer|July 20, 2023
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoidsYuan-Hung Wu, Heng-Sheng Chao, Chi-Lu Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma PatientsMing-Huang Chen, Jing-Jie Weng, Chi-Tung Cheng, et al.
Oncotarget|January 30, 2016
Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cellsChun-Yu Liu, Ming-Hung Hu, Chia-Jung Hsu, et al.
Annals of Hematology|September 2, 2024
Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantationTsung-Han Yang, Chun-Kuang Tsai, Hao-Yuan Wang, et al.
Experimental & Molecular Medicine|August 12, 2017
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, et al.
Annals of Hematology|June 19, 2013
Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab eraYu-Chung Huang, Chun-Yu Liu, Hsueh-Ju Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Chun-Teng Huang, et al.
Breast Cancer Research : BCR|December 30, 2025
Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR studyLing-Ming Tseng, Chi-Cheng Huang, Ji-Lin Chen, et al.
Breast Cancer Research : BCR|December 15, 2023
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR studyHan-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, et al.
Cancers|September 28, 2023
Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast CancerChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Pageof 30

Showing results (251-260 of 296) with videos related to

Sort By:
Pageof 30
Thoracic Cancer|July 20, 2023
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoidsYuan-Hung Wu, Heng-Sheng Chao, Chi-Lu Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2016
ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma PatientsMing-Huang Chen, Jing-Jie Weng, Chi-Tung Cheng, et al.
Oncotarget|January 30, 2016
Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cellsChun-Yu Liu, Ming-Hung Hu, Chia-Jung Hsu, et al.
Annals of Hematology|September 2, 2024
Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantationTsung-Han Yang, Chun-Kuang Tsai, Hao-Yuan Wang, et al.
Experimental & Molecular Medicine|August 12, 2017
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, et al.
Annals of Hematology|June 19, 2013
Comparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab eraYu-Chung Huang, Chun-Yu Liu, Hsueh-Ju Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Chun-Teng Huang, et al.
Breast Cancer Research : BCR|December 30, 2025
Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR studyLing-Ming Tseng, Chi-Cheng Huang, Ji-Lin Chen, et al.
Breast Cancer Research : BCR|December 15, 2023
Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR studyHan-Fang Cheng, Yi-Fang Tsai, Chun-Yu Liu, et al.
Cancers|September 28, 2023
Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast CancerChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Pageof 30